JPMorgan Raises Cogent Biosciences (COGT) PT to $67 on Sector Model Update
Cogent Biosciences Inc. (NASDAQ:COGT) is one of the best emerging technology stocks to invest in.
Cogent Biosciences Inc. (COGT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deerfield Management James E. Flynn | 9,053,118 | $130,002,774 | +243% | 1.98% |
| 2. | Kynam Capital Derrick Tang | 7,886,172 | $113,245,430 | -8% | 8.43% |
| 3. | Commodore Capital Egen Atkinson And Michael Kramarz | 7,250,000 | $104,110,000 | +214% | 5.08% |
| 4. | Octagon Capital Advisors Ting Jia | 2,874,111 | $41,272,234 | +5% | 6.26% |
| 5. | Vivo Capital Albert Cha And Frank Kung | 2,789,137 | $40,052,007 | +149% | 3.22% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.00 | 2,777,777 | $24,999,993.00 | 9,003,418 | 2025-07-10 | Filing | |
| $7.60 | 43,750 | $332,412.50 | 45,848 | 2025-01-14 | Filing | |
| $12.00 | 800,000 | $9,600,000.00 | 3,272,124 | 2023-06-09 | Filing | |
| $8.25 | 1,200,000 | $9,900,000.00 | 2,472,124 | 2022-06-16 | Filing | |
| $2.62 | 101,000 | $264,620.00 | 4,355,273 | 2020-08-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $38.70 | 65,000 | $2,515,500.00 | 109,398 | 2025-12-26 | Filing | |
| $38.68 | 77,000 | $2,978,360.00 | 131,834 | 2025-12-26 | Filing | |
| $38.70 | 82,642 | $3,198,245.40 | 133,938 | 2025-12-26 | Filing | |
| $38.74 | 90,000 | $3,486,600.00 | 140,002 | 2025-12-26 | Filing | |
| $8.86 | 17,813 | $157,823.18 | 3,841 | 2021-04-26 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 22,408,263 | $321,782,656 | 0.02% | |
| 2. | 10,369,535 | $148,906,523 | 0% | |
| 3. | 9,003,418 | $129,289,082 | 11.63% | |
| 4. | 7,757,662 | $111,400,026 | 0% | |
| 5. | 6,798,162 | $97,621,606 | 4.8% |
News See All
12 Best Emerging Technology Stocks to Invest In
On December 24, Kevin Simpson of Capital Wealth Planning joined 'Closing Bell' on CNBC to talk about AI tailwinds and the diverging tech picture.
Will Cogent Biosciences’ (COGT) Breakthrough Therapy Transform GIST Treatment? Analysts Think So
Cogent Biosciences Inc. (NASDAQ:COGT) is among the hottest SMID-cap stocks so far in 2025. On November 13, H.C.
10 Hottest SMID-Cap Stocks So Far In 2025
SMID-caps, or Small- and mid-cap stocks, are often overlooked segments of the market.
Cogent Biosciences (COGT) Soars 126% on Stomach Cancer Treatment Progress
Cogent Biosciences skyrocketed by 126.3 percent week-on-week, as investor sentiment was boosted by the promising results of its last clinical trial that tested the efficacy of its drug candidate for a...
Cogent Biosciences (COGT) Climbs to New Record High on Cancer Treatment Drug Trial
Cogent Biosciences soared to a new seven-year high on Monday, as investors cheered promising results of the last clinical trial phase that tested the efficacy of its drug candidate for a type of stomach...
Cogent Biosciences Rated as a Buy at Citi on Robust Pipeline
Cogent Biosciences, Inc. (NASDAQ:COGT) is one of the best biotech stocks to buy according to billionaire Steve Cohen.
10 Best Biotech Stocks to Buy According to Billionaire Steve Cohen
Steve Cohen, whose success at SAC Capital made him one of the most successful hedge fund managers on Wall Street, is a worried man.
10 Best Small-Cap Stocks to Buy According to Billionaires
On Tuesday, the Dow Jones Industrial Average dropped 0.98%, mainly because of worries about rising US inflation and mixed earnings reports from big banks.
10 Best Low Priced Biotech Stocks to Buy Now
On May 8, Michael Yee, Senior Biotech Analyst at Jefferies, appeared on CNBC to discuss how tariffs and policy risks are pressuring the biotech industry, while simultaneously iterating that low valuations...
Hedge Fund Resource Center Billionaire Hedge Funds
